What's Happening?
NHS England has revealed the first 13 integrated care boards (ICBs) that will serve as early adopters for the single national formulary (SNF). This initiative, announced in a blog on July 9, 2026, aims to transition these ICBs to new categories by December
2026, with the remaining 13 ICBs following by July 2027. The SNF is designed to reduce variations caused by local formularies and eliminate barriers that delay access to clinically and cost-effective treatments. The initial focus will be on four therapy areas: chronic heart failure, type 2 diabetes mellitus in adults, ophthalmology, and asthma, chosen due to their large patient populations and significant public health burdens. The first digital product of the SNF is expected to launch by July 2027, covering 8 to 12 therapy areas.
Why It's Important?
The introduction of a single national formulary is a significant step towards standardizing access to medicines across England, potentially reducing disparities in healthcare. By focusing on therapy areas with large patient populations and complex access pathways, the SNF aims to streamline treatment availability and improve public health outcomes. However, the initiative also faces challenges, such as the risk of exacerbating medicine shortages and stifling innovation, as noted by Olivier Picard, chair of the National Pharmacy Association. The success of the SNF will depend on effective local implementation and the ability to adapt to ongoing NHS reorganizations.
What's Next?
NHS England plans to decide on additional therapy areas for the SNF by the end of 2026. The early adopter ICBs will play a crucial role in testing and refining the formulary's implementation, providing insights that could influence broader adoption. Stakeholders, including local healthcare providers and national organizations, will need to collaborate closely to address potential challenges, such as supply chain issues and the impact on innovation. The outcomes of these pilot sites will likely shape the future of medicine access and healthcare equality in England.
Beyond the Headlines
The SNF initiative highlights the ongoing tension between standardization and innovation in healthcare. While a national formulary could ensure more equitable access to medicines, it may also limit the entry of new treatments into the market. This balance will be critical to maintaining both the quality and availability of healthcare services. Additionally, the SNF's success could serve as a model for other countries seeking to address similar disparities in medicine access.
